S.M.A.I.O S.A. (EPA:ALSMA)

France · Delayed Price · Currency is EUR

6.90

+0.05 (0.73%)

At close: Feb 27, 2026

114.95% (1Y)

Market Cap	38.81M
Revenue (ttm)	5.50M
Net Income (ttm)	-2.35M
Shares Out	5.62M
EPS (ttm)	-0.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	403
Average Volume	1,229
Open	6.95
Previous Close	6.85
Day's Range	6.90 - 7.05
52-Week Range	3.20 - 8.70
Beta	0.68
RSI	51.85
Earnings Date	Apr 14, 2026

About S.M.A.I.O

S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. It offers solutions for surgeons including programs for training, assistance with surgical planning based on a database called KEOPS. The company also offers solutions such as i-PLAN, take control of the realignment plan; i-PERFORM, take control of the surgical plan; i-CHECK, take control of the outcome data; and i-LEARN, take control of the education. S.M.A.I.O S.A. was incorporated in 2009 and is based in Saint-Priest,... [Read more]

Industry Health Information Services

Sector Healthcare

Founded 2009

Employees 41

Stock Exchange Euronext Paris

Ticker Symbol ALSMA

Full Company Profile

Financial Performance

In 2024, S.M.A.I.O's revenue was 5.50 million, an increase of 2.12% compared to the previous year's 5.38 million. Losses were -2.35 million, 426.4% more than in 2023.

Financial Statements

News

There is no news available yet.